These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4539306)

  • 1. Recent advances in the chemotherapy of metastatic osteogenic sarcoma.
    Jaffe N
    Cancer; 1972 Dec; 30(6):1627-31. PubMed ID: 4539306
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 3. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 5. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
    Pratt CB; Roberts D; Shanks EC; Warmath EL
    Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
    Jaffe N; Frei E; Watts H; Traggis D
    Cancer Treat Rep; 1978 Feb; 62(2):259-64. PubMed ID: 346215
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
    Jaffe N
    Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
    Djerassi I
    N Engl J Med; 1975 May; 292(21):1133-4. PubMed ID: 1079317
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose methotrexate for the patient with osteogenic sarcoma.
    Nirenberg A
    Am J Nurs; 1976 Nov; 76(11):1776-80. PubMed ID: 136192
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery.
    Rosen G; Huvos AG; Mosende C; Beattie EJ; Exelby PR; Capparos B; Marcove RC
    Cancer; 1978 Mar; 41(3):841-9. PubMed ID: 305817
    [No Abstract]   [Full Text] [Related]  

  • 12. The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 2005 Sep; 438():19-21. PubMed ID: 16131864
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
    Jaffe N
    Clin Orthop Relat Res; 1976 Oct; (120):95-102. PubMed ID: 1086179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
    Beattie EJ; Martini N; Rosen G
    Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 1991 Sep; (270):4-7. PubMed ID: 1884556
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Limitations of methotrexate and citrovorum-factor treatment.
    Frei E; Jaffe NJ; Pitman S
    N Engl J Med; 1975 Jan; 292(2):107-8. PubMed ID: 1078551
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: A giant step forward - if...
    Burchenal JH
    N Engl J Med; 1974 Nov; 291(19):1029-31. PubMed ID: 4547187
    [No Abstract]   [Full Text] [Related]  

  • 20. New approaches to cancer chemotherapy with methotrexate.
    Frei E; Jaffe N; Tattersall MH; Pitman S; Parker L
    N Engl J Med; 1975 Apr; 292(16):846-51. PubMed ID: 1078714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.